Peter Kuhn

Dr. Kuhn is a scientist, educator and entrepreneur with a career long commitment in personalized medicine and individualized patient care. He is focused on the redesign of cancer care. The first product from technology developed by Dr. Kuhn became available for cancer care in June 2016.

Dr. Kuhn is the Dean’s Professor of Biological Sciences and Professor of Medicine and Engineering, a founding member of the Michelson Center for Convergent Biosciences at USC and is leading CSI-Cancer at USC. Prof. Kuhn’s strategy is to advance our understanding of the human body to improve the human condition. His research is shedding new light at how cancer spreads through the body and evolves over time. This new science will lead to a personalized care strategy that is biologically informed and clinically actionable.  

Dr. Kuhn is a physicist who trained initially at the Julius Maximilians Universität Würzburg, Germany, before receiving his Masters in Physics at the University of Albany, Albany, NY in 1993 and his Ph.D. in 1995. He then moved to Stanford University where he joined the faculties of Medicine and Accelerator Physics. From 2002 to 2014 he established the Physics Oncology program at the Scripps Research in La Jolla, CA before joining USC in 2014. He has published over 200 peer scientific articles and patents as a result of his research. He founded Epic Sciences, Inc. in 2009 to develop cancer diagnostic products. In June 2016, Epic Sciences’ first CLIA certified LDT became available for patient care following the publication of clinical data demonstrating its predictive power.